Calamos Advisors’s Medicines Co MDCO Stock Holding History

Calamos Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-30,000	Closed	-$2.55M	–	836
2019 Q4	$2.55M	Buy	+30,000	New	+$2M	0.01%	592
2013 Q4	–	Sell	-15,840	Closed	-$531K	–	657
2013 Q3	$531K	Sell	15,840 -12,165	-43%	-$388K	﹤0.01%	548
2013 Q2	$861K	Buy	+28,005	New	+$937K	0.01%	467

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Calamos Advisors's MDCO Position: Q1 2020 in Review

Calamos Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 30,000 shares — an estimated $2.55M sold.

Calamos Advisors first reported a position in MDCO in Q2 2013 and held it in 3 quarters. The position peaked at $2.55M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Calamos Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Calamos Advisors sold 30,000 Medicines Co shares in Q1 2020, an estimated $2.55M.
Calamos Advisors first reported a position in Medicines Co in Q2 2013 and held it in 3 quarters.
Calamos Advisors's Medicines Co position peaked at $2.55M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Calamos Advisors's 13F filing for Q1 2020, filed 28 Apr 2020.